Macular Degeneration News and Research

Latest Macular Degeneration News and Research

AI could predict treatment demand for chronic eye diseases

Age-related macular degeneration (AMD) is the most common cause of vision loss in people over 50. Up to 12 percent of those over 80 have the chronic disease.

8 Jun 2021

Researchers identify new approach to clear toxic Huntingtin protein

Researchers world-wide are focused on clearing the toxic mutant Huntingtin protein that leads to neuronal cell death and systemic dysfunction in Huntington's disease (HD), a devastating, incurable, progressive neurodegenerative genetic disorder.

2 Jun 2021

New printable device could restore sight to blind people

A researcher at the University of Sydney is developing a printable device that acts like a retina and could one day restore sight to blind people.

17 May 2021

Research into octopus vision leads to a quick and easy test for incurable sight loss

University of Bristol research into octopus vision has led to a quick and easy test that helps optometrists identify people who are at greater risk of macular degeneration, the leading cause of incurable sight loss.

4 May 2021

New photoreceptors from human pluripotent stem cells restores sight to injured retinas

Tens of millions of people worldwide are affected by diseases like macular degeneration or have had accidents that permanently damage the light-sensitive photoreceptors within their retinas that enable vision.

22 Apr 2021

Gene therapy may offer a new approach to preserving vision in people with retinitis pigmentosa

A gene therapy protects eye cells in mice with a rare disorder that causes vision loss, especially when used in combination with other gene therapies, shows a study published today in eLife.

13 Apr 2021

Researchers identify new potential mechanism for age-related macular degeneration

Using laboratory-grown roundworms as well as human and mouse eye tissue, University of Maryland School of Medicine (UMSOM) researchers have identified a new potential mechanism for age-related macular degeneration-;the leading cause of blindness among older adults.

13 Apr 2021

Researchers make a breakthrough in the quest for an AMD cure

Age-related macular degeneration (AMD), which leads to a loss of central vision, is the most frequent cause of blindness in adults 50 years of age or older, affecting an estimated 196 million people worldwide. There is no cure, though treatment can slow the onset and preserve some vision.

29 Mar 2021

NYSCF is developing new stem cell therapy to treat age-related macular degeneration

The New York Stem Cell Foundation (NYSCF) today announced that they are developing a stem cell therapy to treat patients suffering from age-related macular degeneration (AMD).

22 Mar 2021

A better qPCR pipetting experience with VIAFLO electronic pipettes

INTEGRA Biosciences’ VIAFLO electronic pipettes are making qPCR plate preparation the straightforward process it should be for researchers in the Saint-Geniez lab at Harvard Medical School.

From INTEGRA Biosciences 17 Mar 2021

New study aims to develop alternative treatment for posterior eye diseases

Getting poked in the eye with a sharp object is a cringeworthy thought. However, many patients with posterior eye diseases -- back of the eye diseases such as macular degeneration or diabetic retinopathy -- undergo eye injections through the wall of the eye as a medical treatment on a regular basis.

16 Mar 2021

Research reveals link between proteins causing Alzheimer's disease and age-related sight loss

Newly published research has revealed a close link between proteins associated with Alzheimer's disease and age-related sight loss.

10 Mar 2021

Phase 2 clinical trial is now open at Columbia to test gene therapy for dry macular degeneration

A phase 2 clinical trial is underway at Columbia University and NewYork-Presbyterian to test an investigational gene therapy for dry age-related macular degeneration, a progressive, chronic eye disease with no cure and a leading cause of blindness in the United States.

9 Mar 2021

Buck scientists develop a predictive model to help identify people at risk for severe COVID-19

Researchers at the Buck Institute analyzed data from the COVID-19 Symptom Tracker app used by 3 million people in the United Kingdom, adding the use of immunosuppressant medication, use of a mobility aid, shortness of breath, fever, and fatigue to the list of symptoms and comorbidities that increase the risk for severe COVID-19.

9 Mar 2021

Scientists find new therapeutic approach to effectively treat age-related macular degeneration

Runt-related transcription factor 1 (RUNX1) has been linked to retinal neovascularization and the development of abnormal blood vessels, which result in vision loss in diabetic retinopathy.

22 Feb 2021

Novel vectors reduce the risks associated with ocular gene therapies

Strategies based on the use of gene therapy to mitigate the effects of mutations that cause blindness are undergoing rapid development.

22 Feb 2021

New method can help evaluate potential sight-preserving properties

Scientists like the John A. Moran Eye Center's Paul S. Bernstein, MD, PhD, know a special class of lipids, or fatty acids, found in the retina of the eye and in just a few other parts of the body play an important role in maintaining vision.

5 Feb 2021

New compound may slow aging and age-related diseases

A compound that extends lifespan in a tiny nematode worm slows bone loss in aging mice. That surprising result comes from a longitudinal and functional study of 700 aging mice at the Buck Institute, a project that provides a treasure trove of data for researchers aiming to develop therapeutics to slow aging and age-related diseases.

27 Jan 2021

Trump’s pardons included health care execs behind massive frauds

At the last minute, President Donald Trump granted pardons to several individuals convicted in huge Medicare swindles that prosecutors alleged often harmed or endangered elderly and infirm patients while fleecing taxpayers.

22 Jan 2021

Pioneering new eye test may predict wet AMD three years before symptoms develop

A pioneering new eye test, developed by scientists at UCL in collaboration with the Western Eye Hospital, London, may predict wet AMD, a leading cause of severe sight loss, three years before symptoms develop.

18 Dec 2020

Macular Degeneration News and Research

Latest Macular Degeneration News and Research

AI could predict treatment demand for chronic eye diseases

Researchers identify new approach to clear toxic Huntingtin protein

New printable device could restore sight to blind people

Research into octopus vision leads to a quick and easy test for incurable sight loss

New photoreceptors from human pluripotent stem cells restores sight to injured retinas

Gene therapy may offer a new approach to preserving vision in people with retinitis pigmentosa

Researchers identify new potential mechanism for age-related macular degeneration

Researchers make a breakthrough in the quest for an AMD cure

NYSCF is developing new stem cell therapy to treat age-related macular degeneration

A better qPCR pipetting experience with VIAFLO electronic pipettes

New study aims to develop alternative treatment for posterior eye diseases

Research reveals link between proteins causing Alzheimer's disease and age-related sight loss

Phase 2 clinical trial is now open at Columbia to test gene therapy for dry macular degeneration

Buck scientists develop a predictive model to help identify people at risk for severe COVID-19

Scientists find new therapeutic approach to effectively treat age-related macular degeneration

Novel vectors reduce the risks associated with ocular gene therapies

New method can help evaluate potential sight-preserving properties

New compound may slow aging and age-related diseases

Trump’s pardons included health care execs behind massive frauds

Pioneering new eye test may predict wet AMD three years before symptoms develop

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Macular Degeneration News and Research

Latest Macular Degeneration News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in